Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 74 articles: HTML format

Single Articles

June 2025
1. CALLAGHAN T, Wise LA, Regan AK
   Intention to Use RSVpreF Vaccine or Nirsevimab to Prevent Infant RSV Among Pregnant Individuals.
   Pediatr Infect Dis J. 2025 Jun 3. doi: 10.1097/INF.0000000000004889.
   PubMed     Abstract available
   
   
   
2. FAFI I, Cohen R, Levy C, Varon E, et al
   High Mortality Due to Pneumococcal Meningitis in Children With Sickle Cell Disease: A French Multicenter Observational Study From 2001 to 2021.
   Pediatr Infect Dis J. 2025;44:496-502.
   PubMed     Abstract available
   
   
   May 2025
3. GENTILE A, Juarez MDV, Lucion MF, Gregorio G, et al
   Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus-associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case-control Study.
   Pediatr Infect Dis J. 2025 May 28. doi: 10.1097/INF.0000000000004878.
   PubMed     Abstract available
   
   
   
4. PLOTKIN SA
   Bring Back Vaccinia!
   Pediatr Infect Dis J. 2025 May 21. doi: 10.1097/INF.0000000000004863.
   PubMed    
   
   
   April 2025
5. ARRIETA AC, Osborne S, Grant LR, Gessner BD, et al
   Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis.
   Pediatr Infect Dis J. 2025 Apr 21. doi: 10.1097/INF.0000000000004833.
   PubMed     Abstract available
   
   
   
6. CAVALCANTE LRL, Los DB, Fiorenza NG, Kehdi RC, et al
   Maternal Immunization Against SARS-CoV-2 and Infant Immunity Persistence in a Brazilian Cohort.
   Pediatr Infect Dis J. 2025 Apr 9. doi: 10.1097/INF.0000000000004817.
   PubMed     Abstract available
   
   
   
7. BUTIC I, Tesovic G, Bodulic K, Lucic S, et al
   Impact of Universal PCV10 Vaccination on Invasive Pneumococcal Disease in Croatian Children.
   Pediatr Infect Dis J. 2025 Apr 8. doi: 10.1097/INF.0000000000004821.
   PubMed     Abstract available
   
   
   March 2025
8. FALLACH N, Lasalvia P, Pawaskar M, Chodick G, et al
   Impact of Universal Varicella Vaccination in Israel: A Time-Series Analysis, 2003 to 2020.
   Pediatr Infect Dis J. 2025 Mar 19. doi: 10.1097/INF.0000000000004787.
   PubMed     Abstract available
   
   
   
9. MCALISTER SM, van den Biggelaar AHJ, Cooper MN, Thornton R, et al
   Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses.
   Pediatr Infect Dis J. 2025 Mar 5. doi: 10.1097/INF.0000000000004764.
   PubMed     Abstract available
   
   
   
10. EGESKOV-CAVLING AM, Johannesen CK, Folke F, Fischer TK, et al
    Evaluating the Impact of Moderate and Severe Varicella Infections on Danish Children Under 18 Years Old: A Comprehensive Analysis From 2015 to 2023.
    Pediatr Infect Dis J. 2025;44:270-276.
    PubMed     Abstract available
    
    
    February 2025
11. ISLAM K, Sancho-Shimizu V, Kampmann B, Diavatopoulos D, et al
    Heterologous Effects of Pertussis and Influenza Vaccines During Pregnancy on Maternal and Infant Innate Immune Responses: A Pilot Study.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
12. DANIEL O, Loughnan M, Quenby M, Chawla K, et al
    Antibody in Breastmilk Following Pertussis Vaccination in Three-time Windows in Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
13. CASTRELLON PARDO M, Bruce M, Surti MS, Myers-Stewart M, et al
    A Qualitative, Patient-led Exploration of Vaccination Communication Preferences Among a Diverse Sample of Pregnant, Postpartum, Breastfeeding Canadians.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
14. KUNTZ JL, Babu TM, Feldstein LR, Englund JA, et al
    Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
15. PAULSON S, Munro APS, Cathie K, Bedford H, et al
    Protecting Against Respiratory Syncytial Virus: An Online Questionnaire Study Exploring UK Parents' Acceptability of Vaccination in Pregnancy or Monoclonal Antibody Administration for Infants.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
16. SOSA M, Haghighi C, Pike M, Stolarczuk JE, et al
    Perception of a Novel Group B Streptococcus Vaccine Among Pregnant and Lactating Individuals.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
17. KYOHERE M, Nalubega P, Ssemere H, Ssali A, et al
    Increasing Maternal Vaccination Awareness, by Working With Women Influencers in Kawempe Division, Uganda: A Brief Report.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
18. DE BRABANDERE L, Hanning N, Hendrickx G, Van Damme P, et al
    Vaccine Confidence During Pregnancy and the Impact of the COVID-19 Pandemic: A Wide Variety of Views Across the European Union.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
19. QUINCER EM, Gobezayehu AG, Belew ML, Endalamaw LA, et al
    High Intention to Vaccinate Against Tuberculosis During Pregnancy and Lactation: Understanding Vaccine-specific Maternal Immunization Acceptance in Amhara, Ethiopia.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
20. NAMBASA VP, Ssebagereka A, Ssali A, Namugumya R, et al
    Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
21. NYIRO JU, Bukusi E, Mureithi MW, Walumbe D, et al
    Prevalence and Predictors of Adverse Birth Outcomes and Their Implications in Assessing the Safety of New Maternal Vaccines in Kenya.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
22. BERRUETA M, Ciapponi A, Bardach A, Ballivan J, et al
    Safe in Pregnancy and Safe in Children: Global Living Systematic Reviews and Meta-analyses Hub for Emergency Vaccines.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
23. REGAN AK, Rowe SL
    Use of Routinely Collected "Real-world" Data for the Postlicensure Safety Assessment of Vaccination During Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
24. NALEWAY AL, Crane B, Irving SA, Daley MF, et al
    Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
25. NOGUCHI L, Njogu R, Morgan C, Yunus S, et al
    Facility Readiness Assessment for Maternal Immunization: Results of Field Testing in Kenya and Bangladesh.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
26. MOURAO ML, Baca-Arzaga A, Castellanos M, Johnstone R, et al
    Trends in Neonatal Vaccination: A Ten-year Retrospective Study in a Large Delivery Center.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
27. STURROCK S, Davies H, Rukundo G, Komugisha C, et al
    Sociodemographic Factors Associated With Established and Novel Antenatal Vaccination Uptake in a Cohort of Pregnant Women in Uganda.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
28. PALADINO B, Delfino M, Badia F, Pujadas M, et al
    Assessing Vaccine Coverage and Barriers to Immunization Among Pregnant Individuals in Uruguay: A Brief Report.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
29. BOURNE J, Sawry S, Le Roux J, Fairlie L, et al
    Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
30. GENTILE A, Castellano VE, Ulloa-Gutierrez R, Duenas L, et al
    Pertussis Vaccination During Pregnancy: Regional Situation and Impact of Implementation on National Immunization Programs in Latin America.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
31. MASSORA S, Mucavele H, Carvalho MDG, Mandomando I, et al
    Effect of the Ten-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease and Pneumonia in Infants Younger Than Ten Weeks of Age in Southern Mozambique: A Population-based Prospective Surveillance Study.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
32. PUTHANAKIT T, Chokephaibulkit K, Anugulruengkitt S, Chaithongwongwatthana S, et al
    Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
33. SASO A, Kampmann B
    What Is the Impact of Maternal Pertussis Immunization in Pregnancy on the Quantity, Quality and Longevity of Infant Vaccine Responses?: A Review of the Current Evidence.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
34. KUNG S, Pike M, Eckert LO, Cheu LA, et al
    Comparative Analysis of Transplacental SARS-CoV-2 Antibody Transfer in Pregnancy Phenotypes With Pre-eclampsia and/or Small-for-gestational-age Infants.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
35. DEESE J, Schaible K, Massierer D, Tingir N, et al
    Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation: Tetanus, Pertussis, Influenza and COVID-19.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
36. STURROCK S, Cavell B, Alexander F, Apostolakis K, et al
    Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
37. BALLIVIAN J, Parker EPK, Berrueta M, Ciapponi A, et al
    Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
38. GENTILE A, Juarez MDV, Lucion MF, Ensinck G, et al
    Respiratory Syncytial Virus Epidemiology in Argentina: From COVID-19 Pandemic to the Maternal Immunization Strategy.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
39. FAY K, Groome MJ, Barsosio H, Seale AC, et al
    How Can We Accelerate Maternal Vaccination Globally?
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
40. KAMPMANN B, Jones CE, Faber H
    Immunizing Pregnant Women and Infants (IMPRINT) Network: Building and Sustaining an Interdisciplinary Network Tackling the Complex Challenges of Vaccination in Pregnancy and Early Life.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    January 2025
41. HAN MS, Choi S, Yoon Y, Kim YK, et al
    Long-Term Response to SARS-CoV-2 mRNA Vaccine in Adolescents.
    Pediatr Infect Dis J. 2025 Jan 28. doi: 10.1097/INF.0000000000004709.
    PubMed     Abstract available
    
    
    
42. LEVY C, Varon E, Bechet S, Bonacorsi S, et al
    Similarities and Differences Between Countries When Estimating the Effect of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media.
    Pediatr Infect Dis J. 2025 Jan 21. doi: 10.1097/INF.0000000000004686.
    PubMed    
    
    
    
43. TACHIKAWA J, Aizawa Y, Ikuse T, Yamanaka T, et al
    Clinical Characteristics of Hospitalized Children With Coronavirus Disease 2019 After the Spread of the BA.5 Omicron Variants in Japan.
    Pediatr Infect Dis J. 2025;44:665-671.
    PubMed     Abstract available
    
    
    
44. HAMILTON K, Luvsansharav UO, Xing W, Gierke R, et al
    Characteristics of Invasive Pneumococcal Diseases Cases Among U.S. Children With Hematologic Malignancies Before and After Introduction of Thirteen-valent Pneumococcal Conjugate Vaccine, 2005-2019.
    Pediatr Infect Dis J. 2025 Jan 17. doi: 10.1097/INF.0000000000004730.
    PubMed     Abstract available
    
    
    
45. YEE JS, Doyle R, Wen SC
    Improved Uptake of Vaccinations in Children With Adverse Events Following Immunization After Specialist Immunization Service Intervention in an Australian Pediatric Hospital.
    Pediatr Infect Dis J. 2025 Jan 7. doi: 10.1097/INF.0000000000004719.
    PubMed     Abstract available
    
    
    
46. PLOTKIN SA
    Do We Need a Lyme Disease Vaccine?
    Pediatr Infect Dis J. 2025;44:32.
    PubMed    
    
    
    
47. BURTON C, Webb R, Anglemyer A, Humphrey A, et al
    Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in Tamaki Makaurau Auckland, Aotearoa New Zealand.
    Pediatr Infect Dis J. 2025;44:90-96.
    PubMed     Abstract available
    
    
    November 2024
48. MUNOZ FM, Beigi R, Posavad CM, Kelly C, et al
    Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
    Pediatr Infect Dis J. 2024;43:1065-1073.
    PubMed     Abstract available
    
    
    
49. OLARTE L, Banerjee D, Swanson D, Tabakh J, et al
    Pneumococcal Colonization in Children With Persistent Asthma: A Retrospective Cohort.
    Pediatr Infect Dis J. 2024;43:1033-1039.
    PubMed     Abstract available
    
    
    October 2024
50. OHNISHI T, Erdem G, Kuno T, Yasuhara J, et al
    mRNA Vaccines: Future Perspectives for Children.
    Pediatr Infect Dis J. 2024 Oct 8. doi: 10.1097/INF.0000000000004557.
    PubMed    
    
    
    
51. TOIZUMI M, Takamatsu M, Toda K, Horikoshi Y, et al
    Progresses Toward Polio Eradication in Asian Countries: Its History and Japan's Contributions.
    Pediatr Infect Dis J. 2024;43:e347-e353.
    PubMed     Abstract available
    
    
    September 2024
52. PLOTKIN SA
    Why Combination Vaccines Are Necessary.
    Pediatr Infect Dis J. 2024 Sep 18. doi: 10.1097/INF.0000000000004476.
    PubMed    
    
    
    
53. DINLEYICI EC, Kurugol Z, Devrim I, Bayram N, et al
    Pediatric Varicella-related Hospitalization in Turkey Between 2008 and 2018: Impact of Universal Single Dose Varicella Vaccine (VARICOMP Study).
    Pediatr Infect Dis J. 2024 Sep 4. doi: 10.1097/INF.0000000000004521.
    PubMed     Abstract available
    
    
    
54. OLUWASEUN S, Cagnan L, Xausa I, Nachbar RB, et al
    Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Pediatr Infect Dis J. 2024;43:902-908.
    PubMed     Abstract available
    
    
    
55. PLOTKIN SA
    Multiple Questions About Protection From Respiratory Syncytial Virus.
    Pediatr Infect Dis J. 2024;43:867-868.
    PubMed    
    
    
    
56. KUS S, Elvan-Tuz A, Aslan-Saritas U, Yilmaz D, et al
    Brain Abscess Developing After Lobar Pneumonia: A Rare Complication in Unvaccinated Child Caused by Streptococcus pneumoniae Serotype 14.
    Pediatr Infect Dis J. 2024;43:e338-e339.
    PubMed    
    
    
    August 2024
57. BURGESS C, Lisul B, Pawaskar M, Petigara T, et al
    Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-Up Efforts for Serbia.
    Pediatr Infect Dis J. 2024 Aug 2. doi: 10.1097/INF.0000000000004487.
    PubMed     Abstract available
    
    
    July 2024
58. KOBBE R, Rau C, Schulze-Sturm U, Stahl F, et al
    Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children.
    Pediatr Infect Dis J. 2024 Jul 30. doi: 10.1097/INF.0000000000004488.
    PubMed     Abstract available
    
    
    
59. LEE ES, Choe YJ, Choe SA, Gwak ES, et al
    Relative Effectiveness of the NVX-CoV2373 Vaccine Compared With the BNT162b2 Vaccine in Adolescents.
    Pediatr Infect Dis J. 2024 Jul 3. doi: 10.1097/INF.0000000000004463.
    PubMed     Abstract available
    
    
    
60. XIAO G, Zhu T, Wang Z, Xie X, et al
    Pentavalent Rotavirus Vaccine Coverage and Trends in Rotavirus Detection Before and After This Vaccination in Chengdu, China.
    Pediatr Infect Dis J. 2024 Jul 2. doi: 10.1097/INF.0000000000004441.
    PubMed     Abstract available
    
    
    June 2024
61. OLUWASEUN S, Cagnan L, Xausa I, Nachbar RB, et al
    Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Pediatr Infect Dis J. 2024 Jun 25. doi: 10.1097/INF.0000000000004448.
    PubMed     Abstract available
    
    
    
62. DEMIRBUGA A, Keskindemir G, Onal Z, Dede E, et al
    Bacillus Calmette-Guerin Vaccine-associated Complications in Immunodeficient Patients Following Liver Transplantation.
    Pediatr Infect Dis J. 2024 Jun 25. doi: 10.1097/INF.0000000000004456.
    PubMed    
    
    
    
63. SOONTHORNARRAK K, Limrungsikul A, Apiwattanakul N
    Comparison of Hepatitis B Surface Antibody Levels After Vaccination With Combined One Dose of Hexavalent Vaccine and Two Doses of Pentavalent Vaccine Versus Three Doses of Pentavalent Vaccine.
    Pediatr Infect Dis J. 2024 Jun 24. doi: 10.1097/INF.0000000000004449.
    PubMed     Abstract available
    
    
    
64. KAUR R, Schulz S, Sherman A, Andrejko K, et al
    Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media.
    Pediatr Infect Dis J. 2024 Jun 5. doi: 10.1097/INF.0000000000004413.
    PubMed     Abstract available
    
    
    
65. BANDYOPADHYAY AS, Burke RM, Hawes KM
    Polio Eradication: Status, Struggles and Strategies.
    Pediatr Infect Dis J. 2024;43:e207-e211.
    PubMed    
    
    
    May 2024
66. MAYTUM A, Porter D, de Whalley P, Thompson A, et al
    The Impact of Infant Bacille Calmette-Guerin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
    Pediatr Infect Dis J. 2024 May 8. doi: 10.1097/INF.0000000000004373.
    PubMed     Abstract available
    
    
    
67. LIN W, Wang B, Wang M, Wang Y, et al
    The Unneglectable Disease Burden of Otitis Media Among Children in China: A Systematic Review and Meta-analysis.
    Pediatr Infect Dis J. 2024;43:403-409.
    PubMed     Abstract available
    
    
    April 2024
68. PLOTKIN SA
    We Need a New Mumps Vaccine.
    Pediatr Infect Dis J. 2024;43:350.
    PubMed    
    
    
    March 2024
69. SENDERS S, Klein NP, Tamimi N, Thompson A, et al
    A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004334.
    PubMed     Abstract available
    
    
    
70. PLOTKIN SA, Offit P
    Efficacy of Rotavirus Vaccines.
    Pediatr Infect Dis J. 2024 Mar 20. doi: 10.1097/INF.0000000000004319.
    PubMed    
    
    
    
71. MEYER J, Silas P, Ouedraogo GL, McElwee K, et al
    A Phase 3, Single-Arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
    Pediatr Infect Dis J. 2024 Mar 15. doi: 10.1097/INF.0000000000004318.
    PubMed     Abstract available
    
    
    
72. MAROM T, Ovnat Tamir S
    Pediatric Otitis Media in the New Pneumococcal Conjugate Vaccines Era: What's Next?
    Pediatr Infect Dis J. 2024 Mar 15. doi: 10.1097/INF.0000000000004323.
    PubMed    
    
    
    
73. KORBAL P, Wysocki J, Jackowska T, Kline M, et al
    Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.
    Pediatr Infect Dis J. 2024 Mar 8. doi: 10.1097/INF.0000000000004300.
    PubMed     Abstract available
    
    
    February 2024
74. 
    Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared With Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance: ERRATUM.
    Pediatr Infect Dis J. 2024;43:186.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.